CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC
Study sponsor: BioAtla, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-07-09Actual
Enrollment · participants85Actual
Source updated2025-09-25Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.